New graft technique offers hope for patients with complex aneurysms
NCT ID NCT01538056
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether specially modified endovascular grafts can safely treat juxtarenal aortic aneurysms—a type of bulge in the main belly artery near the kidney arteries. The grafts are either modified by the doctor or made by a company, and are used in patients who have few other options. The trial aims to enroll 500 adults and will check for safety and success in delivering the graft without leaks or other problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fenestrated endovascular graft (physician-modified or company-manufactured)
- What this could lead to
- If successful, this could provide a safer, less invasive treatment option for patients with complex aortic aneurysms who have few alternatives.
- What could go wrong
- This is an early-stage study without a control group, so results may not apply broadly. Risks include major adverse events like endoleaks or graft migration.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harborview Medical Center
RECRUITINGSeattle, Washington, 98104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.